BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 15196856)

  • 1. Cost-effectiveness analysis of the treatment for intermediate risk endometrial cancer: postoperative brachytherapy vs. observation.
    Fanning J; Hoffman ML; Andrews SJ; Harrah AW; Feldmeier JJ
    Gynecol Oncol; 2004 Jun; 93(3):632-6. PubMed ID: 15196856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment for early endometrial cancer. Cost-effectiveness analysis.
    Fanning J
    J Reprod Med; 1999 Aug; 44(8):719-23. PubMed ID: 10483543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival of intermediate risk endometrial cancer (stage IG3, IC, II) treated with full lymphadenectomy and brachytherapy without teletherapy.
    Fanning J
    Gynecol Oncol; 2001 Aug; 82(2):371-4. PubMed ID: 11531297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of adjuvant radiotherapy in intermediate risk endometrial cancer.
    Rankins NC; Secord AA; Jewell E; Havrilesky LJ; Soper JT; Myers E
    Gynecol Oncol; 2007 Aug; 106(2):388-93. PubMed ID: 17509672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma.
    Cohn DE; Huh WK; Fowler JM; Straughn JM
    Obstet Gynecol; 2007 Jun; 109(6):1388-95. PubMed ID: 17540812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
    Alektiar KM; Venkatraman E; Chi DS; Barakat RR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential benefit of lymphadenectomy for the treatment of node-negative locally advanced uterine cancers.
    Seago DP; Raman A; Lele S
    Gynecol Oncol; 2001 Nov; 83(2):282-5. PubMed ID: 11606085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal vault brachytherapy as sole postoperative treatment for low-risk endometrial cancer.
    Chong I; Hoskin PJ
    Brachytherapy; 2008; 7(2):195-9. PubMed ID: 18358790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative irradiation in endometrial cancer: still a matter of controversy.
    Jereczek-Fossa BA
    Cancer Treat Rev; 2001 Feb; 27(1):19-33. PubMed ID: 11237775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose rate brachytherapy for Stage I/II papillary serous or clear cell endometrial cancer.
    DuBeshter B; Estler K; Altobelli K; McDonald S; Glantz C; Angel C
    Gynecol Oncol; 2004 Aug; 94(2):383-6. PubMed ID: 15297176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-year data on 138 patients with endometrial carcinoma and postoperative vaginal brachytherapy alone: no need for external-beam radiotherapy in low and intermediate risk patients.
    Röper B; Astner ST; Heydemann-Obradovic A; Thamm R; Jacob V; Hölzel D; Schmalfeldt B; Kiechle-Bahat M; Höss C; Molls M
    Gynecol Oncol; 2007 Dec; 107(3):541-8. PubMed ID: 17884152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant vaginal brachytherapy alone for high risk localized endometrial cancer as defined by the three major randomized trials of adjuvant pelvic radiation.
    McCloskey SA; Tchabo NE; Malhotra HK; Odunsi K; Rodabaugh K; Singhal P; Lele S; Jaggernauth W
    Gynecol Oncol; 2010 Mar; 116(3):404-7. PubMed ID: 19944453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stage IB endometrial cancer. Does lymphadenectomy replace adjuvant radiotherapy?
    Bottke D; Wiegel T; Kreienberg R; Kurzeder C; Sauer G
    Strahlenther Onkol; 2007 Nov; 183(11):600-4. PubMed ID: 17960334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal brachytherapy alone: an alternative to adjuvant whole pelvis radiation for early stage endometrial cancer.
    Jolly S; Vargas C; Kumar T; Weiner S; Brabbins D; Chen P; Floyd W; Martinez AA
    Gynecol Oncol; 2005 Jun; 97(3):887-92. PubMed ID: 15943991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer.
    Lin LL; Mutch DG; Rader JS; Powell MA; Grigsby PW
    Gynecol Oncol; 2007 Jul; 106(1):215-20. PubMed ID: 17482665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer.
    Papanikolaou A; Kalogiannidis I; Goutzioulis M; Misailidou D; Makedos A; Vergote I; Makedos G
    Arch Gynecol Obstet; 2006 May; 274(2):91-6. PubMed ID: 16518607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endometrial carcinoma: which radiotherapy for which patient?].
    Barillot I; Maingon P
    Cancer Radiother; 2003 Nov; 7 Suppl 1():1s-7s. PubMed ID: 15124538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologic stage I-II endometrial carcinoma in the elderly: radiotherapy indications and outcome.
    Citron JR; Sutton H; Yamada SD; Mehta N; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1432-8. PubMed ID: 15275729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of vaginal recurrence of stage I endometrial adenocarcinoma with postoperative vaginal radiation.
    Marchetti DL; Piver MS; Tsukada Y; Reese P
    Obstet Gynecol; 1986 Mar; 67(3):399-402. PubMed ID: 3945452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.